| Patents for A61P 33 - Antiparasitic agents (21,787) |
|---|
| 04/08/2009 | EP2043657A2 Use of stilbene derivatives for treatment and prevention of aquatic mold infections |
| 04/08/2009 | EP2043656A2 New medical use of triazine derivatives |
| 04/08/2009 | EP2043620A2 Compositions and methods for treating parasitic infections |
| 04/08/2009 | EP1706114A4 Chemical inhibitors of soluble adenylyl cyclase (sac) |
| 04/08/2009 | EP1461340B1 Trioxane derivatives as antimalaria or anticancer compounds |
| 04/08/2009 | CN101401881A Chinese medicinal composition for treating poison produced by venomous insects |
| 04/08/2009 | CN101401784A Sodium closantel injection formulation and preparation method thereof |
| 04/08/2009 | CN101401782A Doractin dashing agent and method of preparing the same |
| 04/08/2009 | CN100475843C Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 04/08/2009 | CN100475265C A chicken Coccidiosis pill form vaccine and preparation method thereof |
| 04/07/2009 | US7514456 Nicotinamide derivatives useful as p38 inhibitors |
| 04/07/2009 | US7514087 Administering primer and boosting composition comprising source of one or more CD8+ T cell epitopes of melanoma from a source of non-replicating or replication-deficient recombinant poxvirus vector in the human |
| 04/07/2009 | CA2341968C Pyrrolobenzodiazepine compounds |
| 04/07/2009 | CA2341471C Pyrrolbenzodiazepines |
| 04/07/2009 | CA2297112C Dicyclanil polymorphs and hydrates and their preparation |
| 04/02/2009 | WO2009040552A2 Substituted imidazo (2, 1-b) -1, 3, 4-thiazole compounds, their pharmaceutical compositions and uses thereof |
| 04/01/2009 | EP2041089A1 Substituted 1-(azolin-2-yl)-amino-2-aryl-1-hetaryl-ethane compounds |
| 04/01/2009 | EP2040695A2 Methods for the formulation and manufacture of artesunic acid for injection |
| 04/01/2009 | EP1572241B1 Oral pharmaceutical compositions comprising cyclosporin |
| 04/01/2009 | CN101400352A Compositions and methods for the treatment and prevention of disease |
| 04/01/2009 | CN101397558A Clone, expression and use of schistosoma japonicum membrane protein gene TSP2 |
| 04/01/2009 | CN101397342A Anti-schistosoma japonicum monoclonal antibody NP11-4 chimeric Fab antibody, preparation method and use |
| 04/01/2009 | CN101396556A Immunoregulation DNA vaccine capable of preventing chicken Eimeria maxima |
| 04/01/2009 | CN100473651C Pyrazolyl-substituted heterocycles and use thereof as phytosanitary products |
| 03/26/2009 | WO2009039102A1 Inhibitors of copn (cpn) for the treatment of bacterial infections |
| 03/26/2009 | WO2009037485A1 Antibacterial agents |
| 03/26/2009 | WO2008116641A3 Oleyl phosphocholine |
| 03/26/2009 | US20090082345 Benzothiazole- and benzooxazole-4,7-dione, derivatives and their use as cdc25 phosphate inhibitors |
| 03/26/2009 | US20090082283 Dipeptides for Prevention of Muscle Breakdown and Microbial Infection |
| 03/26/2009 | US20090082274 Collections of repeat proteins comprising repeat modules |
| 03/26/2009 | US20090081729 Compositions and Methods Comprising a Ligand of ChemerinR |
| 03/26/2009 | US20090081216 Treatment of pathologies which escape the immune response, using optimized antibodies |
| 03/25/2009 | EP2037958A2 A hybrid cell vaccine against leishmaniasis [kala-azar] |
| 03/25/2009 | EP1681280B1 Novel phenol derivatives and antitrypanosoma preventive/therapeutic agent containing the same as active ingredient |
| 03/25/2009 | EP1476539B1 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins |
| 03/25/2009 | CN101395172A Novel antimicrobial peptides and use thereof |
| 03/25/2009 | CN101395143A Aza heterocyclics for the treatment of malaria or aids |
| 03/25/2009 | CN101394852A Heterocyclic aspartyl protease inhibitors, preparation and use thereof |
| 03/24/2009 | US7507725 Compounds with sulphonamide group and pharmaceutical compositions containing these compounds |
| 03/24/2009 | US7507414 Therapeutic polypeptide with prolonged shelf-life and increased half life for use in treatment of cell proliferative, cardiovascular, inflammatory and autoimmune disorders |
| 03/24/2009 | CA2390558C Use of polysiloxanes containing quaternary amino groups as formulation auxiliary agents, and agents containing the same |
| 03/24/2009 | CA2348579C Azadirachtin compounds extracted from azadirachta indica, compositions and use thereof as insecticidal |
| 03/19/2009 | WO2009035908A1 Compositions and their use for the treatment of protozoal infections comprising metaflumi zone |
| 03/19/2009 | WO2009035160A1 Candidate molecule for falciparum malaria vaccine |
| 03/19/2009 | WO2009035004A1 Substituted isoxazoline compound and pest control agent |
| 03/19/2009 | WO2009033706A1 Increasing the in vivo biological activity of biologically active compounds |
| 03/19/2009 | WO2009033689A1 Piperidone derivatives and medical uses thereof |
| 03/19/2009 | WO2009033494A1 1- or 2-substituted artemisinin derivatives for increasing the in vivo biological activity of biologically active compounds |
| 03/19/2009 | US20090076072 Deuterium-enriched tafenoquine |
| 03/19/2009 | US20090075918 Veterinarian composition comprising an organic salt of levamisole in combination with at least one avermectine and/or milbemycine |
| 03/19/2009 | US20090074859 Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| 03/19/2009 | US20090074783 isolated and purified protein produced by a naturally occurring Babesia sp. and an isolated and purified nucleic acid encoding the above protein; use in diagnosing and treating a mammal infected with a Babesia sp. |
| 03/19/2009 | CA2698973A1 1- or 2-substituted artemisinin derivatives for increasing the in vivo biological activity of biologically active compounds |
| 03/18/2009 | EP2036556A1 Piperidone derivatives and medical uses thereof |
| 03/18/2009 | EP2034986A2 High dose oral pharmaceutical compositions of artemether and lumefantrine |
| 03/18/2009 | EP1713466B1 Antiparasitic composition containing an organic amine salt of closantel |
| 03/18/2009 | EP1539927B1 Probiotic bacterium: lactobacillus fermentum |
| 03/18/2009 | EP1453810B1 Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition to a medicament containing same |
| 03/18/2009 | CN101385704A Compound sulfamonomethoxine sodium injection and preparation method thereof |
| 03/18/2009 | CN100469363C Therapeutic combinations of fatty acids |
| 03/17/2009 | US7504483 α-β C4BP-type recombinant heteromultimeric proteins |
| 03/12/2009 | WO2009032773A2 Compositions and methods for treating demodex infestations |
| 03/12/2009 | WO2009032406A1 Dentifrice compositions for treating xerostomia |
| 03/12/2009 | WO2008094737A3 Purine compounds and compositions as kinase inhibitors for the treatment of plasmodium related diseases |
| 03/12/2009 | WO2005046656A3 Use of 5 - chloro-1- (2, 6 - dichloro - 4 - trifluoromethylphenyl) - 4 - (4, 5 - dicyano - 1h - imidazol - 2yl) -3 - methyl - 1h - pyrazole in systemic control of acarid infestation on animals |
| 03/12/2009 | US20090069386 Liquid Composition, Process for Producing the Liquid Composition,and Ectoparasite Controlling Agent for Use in Mammals and Avians |
| 03/12/2009 | US20090069322 N-formyl hydroxylamine derivatives as inhibitors of bacterial polypeptide formylase for treating microbial infections |
| 03/12/2009 | US20090068641 Highly conserved genes and their use to generate probes and primers for detection of microorganisms |
| 03/12/2009 | US20090068248 Polydiazeniumdiolated cyclic polyamines with polyphasic nitric oxide release and related compounds, compositions comprising same and methods of using same |
| 03/12/2009 | CA2698528A1 Animal parasite-control method using insect growth regulators |
| 03/12/2009 | CA2694767A1 Compositions and methods for treating demodex infestations |
| 03/12/2009 | CA2690011A1 Dentifrice compositions for treating xerostomia |
| 03/11/2009 | EP2033950A1 Substituted tetracycline compounds |
| 03/11/2009 | EP2033648A2 Sustained release drug delivery system containing codrugs |
| 03/11/2009 | EP2033512A1 Model animal of dendritic cell immunoreceptor gene knockout disease |
| 03/11/2009 | EP2032561A2 Dual molecules containing a peroxide derivative, their synthesis and therapeutic uses |
| 03/11/2009 | EP1611111B1 Process for resolving 2,4-diamino-3,6-dihydro-1,3,5-triazines, useful for the treatment of disorders associated with insulin resistance syndrome |
| 03/11/2009 | CN101384613A Novel antimicrobial peptides and use thereof |
| 03/11/2009 | CN101381681A Improved methods for producing oocysts |
| 03/11/2009 | CN101381346A Nimorazole derivates for therapy |
| 03/11/2009 | CN100467494C Organic medicine and betacyclodextrin derivative and preparation process thereof |
| 03/11/2009 | CN100467440C Quaternary bis-ammonium salt precursors and their uses as prodrugs having an antiparasitic activity |
| 03/10/2009 | US7501511 Process for resolving aimines that are useful for the treatment of disorders associated with insulin resistance syndrome |
| 03/05/2009 | WO2009026858A1 Derivatives of acridinone as anti-parasitic, anti-fungal and anti-viral agents |
| 03/05/2009 | WO2009010298A8 Paullone derivatives and its use |
| 03/05/2009 | US20090062362 Veterinary Formulation for Administration of a Water-Insoluble Drug to a Target Animal Through a Water Distribution System |
| 03/05/2009 | US20090061025 Compositions and methods for treating demodex infestations |
| 03/05/2009 | US20090060935 Amebiasis vaccine |
| 03/05/2009 | US20090060911 Enhancement of antibody-mediated immune responses |
| 03/04/2009 | EP2030969A1 Spirocyclic 3-phenyl-3-substituted 4-ketolactams and 4-ketolactones |
| 03/04/2009 | EP2030621A1 Novel substituted pyrimidines as cysteine protease inhibitors |
| 03/04/2009 | EP1453507B1 Solubilized topoisomerase poison agents |
| 03/04/2009 | EP0988054B1 Method and compositions for preventing and treating the systemic inflammatory response syndrome including sepsis |
| 03/04/2009 | CN101375856A Compound ivermectin injection and preparation method |
| 03/03/2009 | US7498340 Topoisomerase I inhibitors; improved stability, water solubility, toxicity; anticancer agents; camptothecins bearing an oxime group in position 7; 7-tert-butoxyiminomethyl-20-O-(4-trimethyl-ammonium-3-hydroxy)butanoyl-camptothecin bromide; glioma |
| 03/03/2009 | US7498334 Pyrrolopyrimidines as phosphodiesterase VII inhibitors |
| 03/03/2009 | US7498306 E4 or F4 and Bcl-2 peptides of small dimension (less than 30 amino acids) that bind a PP2A holoenzyme or one of its sub-units, particularly useful as anticancer, antiviral and antiparasitic agents |
| 03/03/2009 | US7498037 Expression vector comprising nucleotide sequences coding malarial proteins for use as tool in generating vaccines against plasmodial infection; immunotherapy; antimalarial agents |
| 03/03/2009 | CA2420222C Orally administered peptides to ameliorate atherosclerosis |
| 03/03/2009 | CA2393197C Control of arthropods in animals with 1-arylpyrazoles |